Near-infrared fluorescent Imaging of matrix metalloproteinase activity after myocardial infarction

被引:171
作者
Chen, JQ
Tung, CH
Allport, JR
Chen, S
Weissleder, R
Huang, PL
机构
[1] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA
[2] Massachusetts Gen Hosp, Div Cardiol, Charlestown, MA USA
[3] Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA
[4] Harvard Univ, Sch Med, Charlestown, MA USA
关键词
matrix metalloproteinases; myocardial infarction; imaging; gelatinase; remodeling;
D O I
10.1161/01.CIR.0000160936.91849.9F
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-We used a molecular probe activated by protease cleavage to image expression of matrix metalloproteinases ( MMPs) in the heart after myocardial infarction. Methods and Results-We synthesized and characterized a near-infrared fluorescent (NIRF) probe that is activated by proteolytic cleavage by MMP2 and MMP9. The NIRF probe was injected into mice at various time points up to 4 weeks after myocardial infarction induced by ligation of the left anterior descending coronary artery. NIRF imaging of MMP activity increased in the infarct region, with maximal expression at 1 to 2 weeks, persisting to 4 weeks. Zymography and real-time polymerase chain reaction analysis showed that MMP9 expression is increased at 2 to 4 days, and MMP2 expression is increased at 1 to 2 weeks. Dual-label confocal microscopy showed colocalization of NIRF imaging with neutrophils on day 2, and flow cytometric analysis confirmed that NIRF signal is associated with leukocytes in the infarct zone. Conclusions-This study demonstrates that the activity of MMPs in the myocardium may be imaged by use of specific activity-dependent molecular probes.
引用
收藏
页码:1800 / 1805
页数:6
相关论文
共 39 条
[1]   Progressive heart failure after myocardial infarction in mice [J].
Bayat, H ;
Swaney, JS ;
Ander, AN ;
Dalton, N ;
Kennedy, BP ;
Hammond, HK ;
Roth, DM .
BASIC RESEARCH IN CARDIOLOGY, 2002, 97 (03) :206-213
[2]   In vivo molecular target assessment of matrix metalloproteinase inhibition [J].
Bremer, C ;
Tung, CH ;
Weissleder, R .
NATURE MEDICINE, 2001, 7 (06) :743-748
[3]   Molecular imaging of MMP expression and therapeutic MMP inhibition [J].
Bremer, C ;
Tung, CH ;
Weissleder, R .
ACADEMIC RADIOLOGY, 2002, 9 :S314-S315
[4]   Effects of chronic treatment with L-arginine on atherosclerosis in ApoE knockout and ApoE/inducible NO synthase double-knockout mice [J].
Chen, JQ ;
Kuhlencordt, P ;
Urano, F ;
Ichinose, H ;
Astern, J ;
Huang, PL .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (01) :97-103
[5]   In vivo imaging of proteolytic activity in atherosclerosis [J].
Chen, JQ ;
Tung, CH ;
Mahmood, U ;
Ntziachristos, V ;
Gyurko, R ;
Fishman, MC ;
Huang, PL ;
Weissleder, R .
CIRCULATION, 2002, 105 (23) :2766-2771
[6]  
Danielsen CC, 1998, J MOL CELL CARDIOL, V30, P1431
[7]   Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction [J].
Ducharme, A ;
Frantz, S ;
Aikawa, M ;
Rabkin, E ;
Lindsey, M ;
Rohde, LE ;
Schoen, FJ ;
Kelly, RA ;
Werb, Z ;
Libby, P ;
Lee, RT .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (01) :55-62
[8]   Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction [J].
Fernandez-Patron, C ;
Stewart, KG ;
Zhang, YL ;
Koivunen, E ;
Radomski, MW ;
Davidge, ST .
CIRCULATION RESEARCH, 2000, 87 (08) :670-676
[9]  
Fernandez-Patron C, 1999, CIRC RES, V85, P906
[10]   Differential regulation of platelet aggregation by matrix metalloproteinases-9 and-2 [J].
Fernandez-Patron, C ;
Martinez-Cuesta, MA ;
Salas, E ;
Sawicki, G ;
Wozniak, M ;
Radomski, MW ;
Davidge, ST .
THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) :1730-1735